FA9D4D02-3B2D-4921-AC7F-67E8C2BB8CB1MRC Clinical Trials Unit as the London Hub for Trials Methodology ResearchResearch GrantMC_EX_G0800814C008C651-F5B0-4859-A334-5F574AB6B57CMRCSUPPLEMENTARY_UNIT_AWARDS19478020B297A48-E114-4BCB-88E2-A8613E43F6F4Considerations in the rationale, design and methods of the Strategic Timing of AntiRetroviral Treatment (START) study.Clinical trials (London, England)a409def97754c3f9b5001e11f39b5b7dBabiker AG2013-01-01http://dx.doi.org/10.1177/174077451244034222547421http://ukpmc.ac.uk/abstract/MED/225474211740-7745http://europepmc.org/abstract/MED/22547421101 SupplJournal Article/Reviewpm_13787_27_22547421